To include your compound in the COVID-19 Resource Center, submit it here.

No vehicle, no problem

MicroRNA mimics step out of the vehicle and get targeted to tumors

A Purdue University team has developed a ligand-targeted method to deliver microRNA (miRNA) mimics to tumors without relying on vehicles or compromising miRNA processing. The researchers think their folate receptor-targeted miRNAs, or “FolamiRs,” could widen the therapeutic window for miRNA therapies by increasing their stability while allowing them to avoid healthy cells and vehicle-driven toxicity.

Individual miRNAs silence post-transcriptional expression of multiple genes, and

Read the full 631 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers